Ata uhi

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease

Oxidative stress plays a pivotal role in the pathogenesis of inflammatory bowel diseases (IBD). Serum free thiols (R-SH) reliably reflect systemic oxidative stress, since they are readily oxidized by reactive species. Here, we aimed to establish concentrations of serum free thiols in IBD and assesse...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Arno R. Bourgonje (Author), Ruben Y. Gabriëls (Author), Martin H. de Borst (Author), Marian L. C. Bulthuis (Author), Klaas Nico Faber (Author), Harry van Goor (Author), Gerard Dijkstra (Author)
Hōputu:	Pukapuka
I whakaputaina:	MDPI AG, 2019-09-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

The role of fecal calprotectin in pediatric disease
mā: Su Jin Jeong
I whakaputaina: (2019)

Value of fecal calprotectin in the diagnosis of chronic inflammatory bowel diseases in children
mā: T.V. Yaroshevska, me ētahi atu.
I whakaputaina: (2018)

Impact of Fecal Calprotectin Measurement for Inflammatory Bowel Disease in Children with Alarm Symptoms
mā: Burcu Güven, me ētahi atu.
I whakaputaina: (2022)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
mā: Cao Y, me ētahi atu.
I whakaputaina: (2021)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
mā: Andrew S. Day, me ētahi atu.
I whakaputaina: (2017)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
mā: Shaun S. C. Ho, me ētahi atu.
I whakaputaina: (2021)

Acute Kidney Injury is Associated with Lowered Plasma-Free Thiol Levels
mā: Lisanne Boekhoud, me ētahi atu.
I whakaputaina: (2020)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
mā: Soheila Moein, me ētahi atu.
I whakaputaina: (2017)

Determination of cytokine profile and fecal calprotectin in patients with inflammatory bowel disease of different activity degree
mā: Ainur Doszhan, me ētahi atu.
I whakaputaina: (2019)

Systematic review on fecal calprotectin in cystic fibrosis
mā: Eduarda Sampaio Lazzarotto, me ētahi atu.
I whakaputaina: (2023)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
mā: Jung Min Yoon, me ētahi atu.
I whakaputaina: (2014)

Fecal Calprotectin Level in Neonates with Necrotizing Enterocolitis
mā: Maha Abdelkader, me ētahi atu.
I whakaputaina: (2019)

Fecal calprotectin and its association with functional dyspepsia in children
mā: Jeanette Manoppo, me ētahi atu.
I whakaputaina: (2020)

Fecal calprotectin levels in preterm infants with and without feeding intolerance
mā: Rehab Moussa, me ētahi atu.
I whakaputaina: (2016)

Fecal calprotectin levels in pediatric cow's milk protein allergy
mā: Dominika Lendvai-Emmert, me ētahi atu.
I whakaputaina: (2022)

Fecal calprotectin levels in preterm infants with and without feeding intolerance
mā: Rehab Moussa, me ētahi atu.
I whakaputaina: (2016)

Dynamic Changes of Fecal Calprotectin and Related Clinical Factors in Neonates
mā: Ji Sook Park, me ētahi atu.
I whakaputaina: (2020)

Fecal calprotectin levels in preterm infants with and without feeding intolerance
mā: Rehab Moussa, me ētahi atu.

Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
mā: Majid Sharbatdaran, me ētahi atu.
I whakaputaina: (2018)

Plasma Free Thiol Levels during Early Sepsis Predict Future Renal Function Decline
mā: Elisabeth C. van der Slikke, me ētahi atu.
I whakaputaina: (2022)

73 The role of fecal calprotectin in predicting activity of inflammatory bowel disease in pediatric age group in dubai hospital, UAE: 2012- 2016
mā: Khalid Abdalbagi
I whakaputaina: (2021)

Fecal Calprotectin Levels Dynamics in Newborns with High-Risk of Necrotizing Enterocolitis
mā: Anna F. Pupysheva, me ētahi atu.
I whakaputaina: (2023)

Fecal Calprotectin as a Future Screening Tool for Large Juvenile Polyps
mā: Farah Khan MD, me ētahi atu.
I whakaputaina: (2015)

Influence of Perinatal Factors on Blood Tryptase and Fecal Calprotectin Levels in Newborns
mā: Justine Paysal, me ētahi atu.
I whakaputaina: (2023)

Supporting the diagnosis of infantile colic by a point of care measurement of fecal calprotectin
mā: Henning Sommermeyer, me ētahi atu.
I whakaputaina: (2022)

Fecal calprotectin, lactoferrin and morbidity associated with immature digestive tract in preterm infants
mā: D.S. Dobryk, me ētahi atu.
I whakaputaina: (2022)

Effect of Different Milk Diet on the Level of Fecal Calprotectin in Very Preterm Infants
mā: Simonetta Costa, me ētahi atu.
I whakaputaina: (2020)

Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.
mā: Amaya L Bustinduy, me ētahi atu.
I whakaputaina: (2013)

Correlation between gut pathogens and fecal calprotectin levels in young children with acute diarrhea
mā: Yanever Angela Lam, me ētahi atu.
I whakaputaina: (2014)

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
mā: Hyeong Ho Jo, me ētahi atu.
I whakaputaina: (2022)

Values of serum intestinal fatty acid-binding protein, fecal calprotectin, and fecal human β-defensin 2 for predicting necrotizing enterocolitis
mā: Sujia Liu, me ētahi atu.
I whakaputaina: (2024)

Local and Systemic Oxidative Stress Biomarkers for Male Infertility: The ORION Study
mā: Anna T. Bergsma, me ētahi atu.
I whakaputaina: (2022)

Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth
mā: Liu Jin-Rong, me ētahi atu.
I whakaputaina: (2012)

Fecal Calprotectin: A Screening Marker for the Early Detection of Necrotizing Enterocolitis among Children in Egypt
mā: Ayman Emil Eskander, me ētahi atu.
I whakaputaina: (2020)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
mā: Su Yeong Kim, me ētahi atu.
I whakaputaina: (2019)

Effect of Curcumin Plus Piperine on Redox Imbalance, Fecal Calprotectin and Cytokine Levels in Inflammatory Bowel Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
mā: Amylly Sanuelly da Paz Martins, me ētahi atu.
I whakaputaina: (2024)

FECAL CALPROTECTIN AS A MARKER OF INFLAMMATION IN THE COLON AT DIFFERENT VARIANTS OF CLOSTRIDIUM DIFFICILE-INFECTIONS COURSE IN CHILDREN
mā: L. N. Mazankova, me ētahi atu.
I whakaputaina: (2015)

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
mā: Satimai Aniwan
I whakaputaina: (2022)

Heterogeneity of Fecal Calprotectin Reflecting Generation of Neutrophil Extracellular Traps (NETs) in the Gut: New Immunoassays Are Available
mā: Magne K. Fagerhol, me ētahi atu.
I whakaputaina: (2022)

Role of Calprotectin as a Biomarker in Periodontal Disease
mā: Lili Wei, me ētahi atu.
I whakaputaina: (2019)